Fibronostics

Fibronostics

Hospital & Health Care, 3452 Lk Lynda Dr, Orlando, Florida, 32817, United States, 11-50 Employees

fibronostics.com

  • facebook
  • twitter
  • LinkedIn

phone no Phone Number: +18*********

Who is FIBRONOSTICS

Fibronostics is a healthcare technology company providing algorithm-based solutions in a variety of diagnostic testing areas, focusing on assessing liver disease existence/progression, bu...

Read More

map
  • 3452 Lk Lynda Dr, Orlando, Florida, 32817, United States Headquarters: 3452 Lk Lynda Dr, Orlando, Florida, 32817, United States
  • 2015 Date Founded: 2015
  • 11-50 Employees: 11-50
  • dollar-icon Revenue: $5 Million to $10 Million
  • tech-icon Active Tech Stack: See technologies

industries-icon Industry: Hospital & Health Care

SIC SIC Code: 8071

checked-icon Does something look wrong? Fix it. | View contact records from FIBRONOSTICS

Fibronostics Org Chart and Mapping

Employees

Brock Smith

General Manager, Americas

Jen N

Data Entry Specialist

Nicole Ward

Customer Operations Manager

signout-image
You are signed out

Sign in to CIENCE GO Data to uncover contact details

crown-icon Free credits every month

Frequently Asked Questions Regarding Fibronostics

Answer: Fibronostics's headquarters are located at 3452 Lk Lynda Dr, Orlando, Florida, 32817, United States

Answer: Fibronostics's phone number is +18*********

Answer: Fibronostics's official website is https://fibronostics.com

Answer: Fibronostics's revenue is $5 Million to $10 Million

Answer: Fibronostics's SIC: 8071

Answer: Fibronostics has 11-50 employees

Answer: Fibronostics is in Hospital & Health Care

Answer: Fibronostics contact info: Phone number: +18********* Website: https://fibronostics.com

Answer: Fibronostics is a healthcare technology company providing algorithm-based solutions in a variety of diagnostic testing areas, focusing on assessing liver disease existence/progression, but also other chronic areas such as coronary heart disease, stroke, diabetes, and obstructive sleep apnea. Fibronostics' LIVERFASt products provide early detection and monitoring for patients with NAFLD & NASH when a diagnosis is often missed due to limited screening with low-sensitivity tools. The current standard for diagnosis is risky and costly with mounting evidence calling for an efficacious and cost-effective non-invasive diagnostic tool. Fibronostics' HealthFACTR tool employes technology to predict risk, providing results for risks of coronary heart disease, stroke, diabetes and fatty liver disease. HealthFACTR enables action-oriented recommendations which allow healthcare professions to determine patients' risk levels and drive better patient care.

Premium Sales Data for Prospecting

  • Sales data across over 200M records

  • Up-to-date records (less decayed data)

  • Accurate Email Lists (real-world tested)

  • Powerful search engine and intuitive interface

lock icon Get Full Access